In silico method
In silico methods, or using computer modelling and simulation (CM&S), is utilised to amplify and accelerate the design, development, testing and regulatory approval of new medical treatments.
IMAGE GALLERY:
NEWS
News
Welcome on Board, Hemolens Diagnostics!
We are delighted to welcome Hemolens Diagnostics as a new member of the Avicenna Alliance!
News
Poll on Computer Modelling & Simulation
The Avicenna Clinical Deployment Task Force, led by Co-Chairs Erica Beaucage-Gauvreau & René Bombien, is engaged to grow a network of professionals with expertise in clinical applications of in silico methodologies, to foster collaboration and knowledge exchange.
News
April 8th - Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development
Join Next Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development! The EU-funded ERAMET project is transforming how orphan and paediatric medicines are developed. By integrating advanced Computational Modelling & Simulation (CM&S) techniques with real-world data, ERAMET is building a transparent ecosystem to support both medicine developers and regulators.
